Navigation Links
New Anti-Clotting Drug Outperforms Plavix
Date:1/13/2010

Trial shows Brilinta boosts patient outcomes with no added bleeding risk

WEDNESDAY, Jan. 13 (HealthDay News) -- A new clot-busting drug, Brilinta, may soon take the place of Plavix in treating patients with acute coronary syndrome, which includes angina and heart attack.

In a new trial, the upstart drug, ticagrelor (Brilinta) reduced the risk of second heart attacks and death without raising the risk of bleeding, as clopidogrel (Plavix) can do.

"For people with acute coronary syndrome, this very well may replace Plavix," said study author Dr. Christopher Cannon, a cardiologist with Brigham and Women's Hospital and an associate professor of medicine at Harvard Medical School, both in Boston. "This is pretty compelling evidence from this trial that ticagrelor is better without any increased risk of bleeding."

An accompanying editorial concurred, while also pointing out that, as always, a "personalized approach to drug selection should be used."

The study is published in the Jan. 14 online edition of The Lancet.

Approval for Brilinta from the U.S. Food and Drug Administration could come late this year, although it's difficult to predict the timing of such decisions, Cannon noted.

The study was funded by AstraZeneca, which makes Brilinta. Earlier results from the trial were presented at several major medical conferences last year. These published results seem to be the final step in solidifying the ascendancy of the new drug over the mainstay, Plavix.

Combined with other blood-thinning therapies now in the pipeline, these findings may also mark the dawn of a new generation of blood thinners, experts say.

Plavix is used with aspirin to prevent blood clots that can lead to heart attacks, stroke and death. It has been the standard of treatment for heart patients for about a decade, Cannon said.

But the drug has its share of problems, namely a lag time bet
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. American Heart Association Late Breaking Clinical Trial Report: Tests Predict Which Patients Are Resistant to Anti-Clotting Therapy During Angioplasty, Stenting
2. New Anti-Clotting Drug Beats Plavix
3. FDA Panel Backs New Anti-Clotting Drug
4. New Anti-Clotting Treatment Urged for Cancer Patients
5. Anti-Clotting Drug as Good as Aspirin at Stopping Second Stroke
6. Anti-Clotting Drug Helps Infants With Heart Ills
7. Anti-Clotting Drug Trial Shortened by Bleeding Problems
8. Researchers identify molecules with interesting anti-clotting properties
9. New Anti-Clotting Drug Shows Promise in Heart Patients
10. Possible safer target for anti-clotting drugs found
11. Small Businesses In Singapore Outmarkets & Outperforms Bigger Players in Tough Economy With Online Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 17, 2015 From the day Dr. Todd ... Texas non-profit organization has empowered young people to create meaningful ... bring fresh water and the Gospel to all of ... Between March 17 and 27, students, faculty and staff raised ... with fresh water and the Good News of Jesus. ...
(Date:4/17/2015)... Enthusiasts of gourmet cuisine and beverages will be ... The event will be held in the heart of downtown ... NW, Grand Rapids, MI 49503) and will feature wine personalities ... are encouraged to savor the food and beverage pairings while ... event will feature seven chefs, including:, ...
(Date:4/17/2015)... 2015 Testosterone treatment lawsuits ( ... prescription medications increases the likelihood that a man ... life-threatening cardiovascular event continue to mount in a ... District of Illinois. According to an updated Statistics ... Multidistrict Litigation (JPML) on April 15th, 1,382 cases ...
(Date:4/17/2015)... Francisco, CA (PRWEB) April 17, 2015 The American ... House event and Free Application Day on April 29. The event ... ACTCM Pioneer Square, located at 555 DeHaro St. in San Francisco, ... 11 a.m. – Check in at the DeHaro campus (room F), ... – Tour of campus, Noon – Light lunch with current students, ...
(Date:4/17/2015)... North Carolina (PRWEB) April 17, 2015 ... Family Dental Care has spent the last four ... dental care, performing procedures ranging from general cleanings to ... host a grand opening at their new office in ... the same services as their Concord office, including denture ...
Breaking Medicine News(10 mins):Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 3Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 4Health News:American College of Traditional Chinese Medicine Hosts Open House 2
... LAKE CITY, Oct. 22 /PRNewswire/, WHAT: In response to the ... Children,s Miracle Network hospitals are on call to answer ... (MRSA), a form of ... antibiotics, and other pediatric medical questions you have., ...
... American Red Cross encourages evacuees to register on Safe ... continue to rage across,Southern California, forcing thousands to evacuate ... help for those who may feel confused,and anxious about ... The Red Cross urges all those who have evacuated ...
... ... Double Adjusted EBITDA in Fourth Quarter of ... 2007, ... of health, beauty, vision, and,pharmacy products, today announced its financial results for the third,quarter ...
... Says VA Refuses to Act in Good Faith ... Oct. 22 The American Federation,of Government Employees ... Florida/South Georgia Veterans Health System (NF/SGVHS), today,criticized the ... act in,good faith with its employees by failing ...
... world,s adults are obese, study finds , , MONDAY, Oct. 22 ... percent of women are now overweight, and 24 percent of ... who looked at data from 63 countries. , The study ... 18-80 (average age 48), living on five continents. All of ...
... of each extraordinary gift to benefit St. Jude ... Children,s Research Hospital -, ... has created five exclusive, over-the-top luxury gifts available for,purchase beginning October ... Jude Children,s Research Hospital. Each extravagant gift was inspired by ...
Cached Medicine News:Health News:Children's Miracle Network Hospital Doctors On Call to Answer Questions About MRSA Infection 2Health News:Southern California Wildfires Continue to Threaten Residential Areas 2Health News:Southern California Wildfires Continue to Threaten Residential Areas 3Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 2Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 3Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 5Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 6Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 7Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 8Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 9Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 10Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 11Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 12Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 13Health News:drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 14Health News:Mismanagement at North Florida/South Georgia Veterans Health System Results in Chronic Staff Shortages, Budget Issues 2Health News:Overweight Now a Global Problem 2Health News:Saks Fifth Avenue Unveils Five Magical Holiday Gifts 2Health News:Saks Fifth Avenue Unveils Five Magical Holiday Gifts 3
(Date:4/17/2015)... , April 17, 2015 ... EGFR mutation   is a viable alternative to tumour biopsy ... testing in all patients with advanced NSCLC   ... effectiveness of plasma circulating tumour DNA (ctDNA) testing for epidermal ... with advanced non-small cell lung cancer (NSCLC) in clinical practice. ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5hkm2f/medical_oxygen ) ... Systems - Global Strategic Business Report" report to ... markets for Medical Oxygen Systems in US$ Thousands by ... Cylinders & Regulators, and Oxygen Conserving Devices. The report ... Canada , Japan , ...
(Date:4/17/2015)... Apr. 16, 2015 Research and Markets ... "Corporate Reputation of Pharma in 2014 - a ... report to their offering. This independent study, ... patient groups with an interest in diabetes on the ... the pharma industry as a whole) in 2014. The ...
Breaking Medicine Technology:"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5
... YORK, Nov. 4, 2010 Reportlinker.com ... report is available in its catalogue: ... Cancer Overview - Metastatic gastrointestinal cancers ... to a lack of approved drugs ...
... YORK, Nov. 4 Reportlinker.com announces that ... in its catalogue: Stakeholder ... - Opportunities in Brazil, Mexico and Argentina ... IntroductionOver the past decade, vaccines ...
Cached Medicine Technology:Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 2Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 3Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 4Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 5Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 6Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 7Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 8Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 9Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 10Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 11Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 12Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 13Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 14Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 15Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 16Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 17Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 2Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 3Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 4Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 5Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 6Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 7Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 8
Straight curette with hollow handle and round cup....
Set of 5 large bone curettes. One each of the following: angled small, straight small, angled medium, straight medium, and angled large....
Bone removing chisel for decortication of lumbar vertebral bodies....
Stainless steel bone clamp....
Medicine Products: